Daptomycin-Induced Pulmonary Toxicity: A Case Series

Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently d...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Yamini I, Natarajan, Sarasija, Ramakrishna, Srinivasarao, Ochieng, Pius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299848/
https://www.ncbi.nlm.nih.gov/pubmed/37384075
http://dx.doi.org/10.7759/cureus.39613
_version_ 1785064457769058304
author Patel, Yamini I
Natarajan, Sarasija
Ramakrishna, Srinivasarao
Ochieng, Pius
author_facet Patel, Yamini I
Natarajan, Sarasija
Ramakrishna, Srinivasarao
Ochieng, Pius
author_sort Patel, Yamini I
collection PubMed
description Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).
format Online
Article
Text
id pubmed-10299848
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102998482023-06-28 Daptomycin-Induced Pulmonary Toxicity: A Case Series Patel, Yamini I Natarajan, Sarasija Ramakrishna, Srinivasarao Ochieng, Pius Cureus Internal Medicine Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP). Cureus 2023-05-28 /pmc/articles/PMC10299848/ /pubmed/37384075 http://dx.doi.org/10.7759/cureus.39613 Text en Copyright © 2023, Patel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Patel, Yamini I
Natarajan, Sarasija
Ramakrishna, Srinivasarao
Ochieng, Pius
Daptomycin-Induced Pulmonary Toxicity: A Case Series
title Daptomycin-Induced Pulmonary Toxicity: A Case Series
title_full Daptomycin-Induced Pulmonary Toxicity: A Case Series
title_fullStr Daptomycin-Induced Pulmonary Toxicity: A Case Series
title_full_unstemmed Daptomycin-Induced Pulmonary Toxicity: A Case Series
title_short Daptomycin-Induced Pulmonary Toxicity: A Case Series
title_sort daptomycin-induced pulmonary toxicity: a case series
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299848/
https://www.ncbi.nlm.nih.gov/pubmed/37384075
http://dx.doi.org/10.7759/cureus.39613
work_keys_str_mv AT patelyaminii daptomycininducedpulmonarytoxicityacaseseries
AT natarajansarasija daptomycininducedpulmonarytoxicityacaseseries
AT ramakrishnasrinivasarao daptomycininducedpulmonarytoxicityacaseseries
AT ochiengpius daptomycininducedpulmonarytoxicityacaseseries

Ejemplares similares